NDC 51662-1657-01 - LIDOCAINE HYDROCHLORIDE AND DEXTROSE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1657
- Requested NDC
- 51662-1657-01
- Package NDCs from labels
- 51662-1657-1, 51662-1657-01
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2026-01-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE AND DEXTROSE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2026-01-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1657-1 | LIDOCAINE HYDROCHLORIDE AND DEXTROSE | 250 mL in 1 BAG | INJECTION, SOLUTION | 250 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1657 | LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 1 | Current NDC, 1 package rows | 20240716_1bf999b5-e290-dcbd-e063-6294a90a2bab.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| American Red Cross First Aid | BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE | MY IMPORTS USA, LLC | 667ab8ce-e110-4b7f-a158-3cdd3b7a1c29 | 2026-09-23 | Warnings | V13007Z41A |
| Sterile Water | WATER | B. Braun Medical Inc. | f4284eb6-e553-46d4-90d8-efc80a90a480 | 2026-09-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 2f94f711-14c4-48ec-c5a3-c5ec4b8e8729 | 2026-09-17 | Warnings, Adverse reactions | V13007Z41A |
| 5Kind Neurophase Pro Pain Relieving | LIDOCAINE HYDROCHLORIDE, MENTHOL | 5KIND TRADING LTD | 72759a1a-6751-4c00-944c-018c2e5f9170 | 2026-09-16 | Warnings | V13007Z41A |
| Dragon Lidocaine Pain | LIDOCAINE HYDROCHLORIDE | Genomma Lab USA | 7f29acd2-a287-4553-a851-c16b183edea6 | 2026-09-16 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Henry Schein, Inc. | 07a2b40b-0386-40d4-b0c4-e69e13610cd9 | 2026-09-14 | Warnings, Adverse reactions | V13007Z41A |
| FlyLeaf RINGWORM TREATMENT | MICONAZOLE NITRATE 2% | Guangzhou Huixue Biotechnology Co., Ltd. | 5b597a3b-b5ff-2246-e063-6394a90a1046 | 2026-09-13 | Warnings | 059QF0KO0R |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | e2638b45-1141-4391-971d-c0dea825e41c | 2026-09-11 | Warnings, Adverse reactions | LX22YL083G |
| Lidocaine 4% Cream | LIDOCAINE 4% | InvaDerm Corporation | 5b3c6a39-f094-8c2d-e063-6394a90a94c3 | 2026-09-11 | Warnings | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | Henry Schein, Inc. | 23c8f711-e458-479a-9ab0-dcc851311e24 | 2026-09-10 | Warnings, Adverse reactions | V13007Z41A |
| Burn Cream | BENZALKONIUM CHLORIDE, LIDOCAINE HCI | Trifecta Pharmaceuticals USA LLC | e9a9fc7c-31da-ea3f-e053-2a95a90a0eab | 2026-09-09 | Warnings | V13007Z41A |
| Burn Gel | LIDOCAINE HCI | Trifecta Pharmaceuticals USA LLC | e9d3e9be-1036-fad0-e053-2a95a90a6efe | 2026-09-09 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Cardinal Health 107, LLC | 32513e8b-2a81-436e-8da2-439c1dcbf116 | 2026-09-09 | Warnings, Adverse reactions | V13007Z41A |
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 8cf6943f-16e8-4521-863c-09bb0b55e2a9 | 2026-09-09 | Warnings, Adverse reactions | LX22YL083G |
| American Safety First Aid | LIDOCAINE HCL | Orazen Inc | ea2f776b-dfd0-6ce4-e053-2995a90af009 | 2026-09-07 | Warnings | V13007Z41A |
| MEDI-FIRST Topical Analgesic | LIDOCAINE HCI | Ultra Distributors Inc | b6f288f7-9ae3-215e-e053-2a95a90aedf6 | 2026-09-07 | Warnings | V13007Z41A |
| MEDI-FIRST | BENZALKONIUM CHLORIDE, LIDOCAINE | Orazen Inc | f508434f-5948-7134-e053-2a95a90a03d7 | 2026-09-05 | Warnings | V13007Z41A |
| MEDI-FIRST | BENZALKONIUM CHLORIDE, LIDOCAINE | Orazen Inc | f522fb0b-3d86-b228-e053-2a95a90a55e9 | 2026-09-05 | Warnings | V13007Z41A |
| Nerve Guard Nerve Relief | LIDOCAINE HYDROCHLORIDE, MENTHOL,MAGNESIUM CHLORIDE | Micelle Laboratories, Incorporated | 6b78f40f-2a7f-4c49-96af-1a95acbf430f | 2026-09-04 | Warnings | V13007Z41A |
| Lidocaine Viscous | LIDOCAINE HYDROCHLORIDE | REMEDYREPACK INC. | 6f8d20d2-6a91-4a5b-bfe8-f1baada38442 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.